Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
17 participants
INTERVENTIONAL
2021-10-05
2025-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Arm 1: Subjects will be exposed to vapor of peppermint oil
* Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physical Therapy for Women With Obstetric Trauma and Anal Incontinence
NCT01672697
Optimizing the Management of Postpartum Urinary Retention
NCT04187365
Postpartum Pelvic Floor Workshop
NCT04754984
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
NCT07125326
Postpartum Pelvic Floor Muscle Training in Women With and Without Injured Pelvic Floor Muscles
NCT01069484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Arm 1: Subjects will be exposed to vapor of peppermint oil
* Arm 2: Subjects will be exposed to vapor of placebo (mineral oil) Outcome variables include resolution of urinary retention, time to spontaneous urination, volume of spontaneous urination, frequency of urinary catheterization, and patient satisfaction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Peppermint Oil
Subjects will be exposed to vapor of peppermint oil
Peppermint oil vapors
Subjects will be exposed to vapor of peppermint oil
Placebo
Subjects will be exposed to vapor of placebo (mineral oil)
Mineral Oil
Subjects will be exposed to vapor of placebo (mineral oil)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peppermint oil vapors
Subjects will be exposed to vapor of peppermint oil
Mineral Oil
Subjects will be exposed to vapor of placebo (mineral oil)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* More than 6 hours after delivery or foley catheter removal without being able to spontaneously void
* Symptomatic urinary retention without being able to spontaneously void
* Change in fundal height or position without being able to spontaneously void 6. Bladder scan showing bladder containing 400mL or more urine
Exclusion Criteria
2. Asthma
3. Active herpes lesions
4. Seizure disorder
5. Not able to void in toilet (ex: requiring use of bed pan to void)
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
TriHealth Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bethesda North Hospital
Cincinnati, Ohio, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.